Maybe I have missed it as I get bored to tears flipping through the interminable posts on self sustaining something and all the other reasons why MSB is a spent force but has there been any discussion at all on AbbeVie's gaining FDA approval for their cGVHD product Imbruvica (acquired from Pharmacyclics at an implied value of $42bn a few years back?) Sales for the first 2 quarters were over $1bn. I understand the difference between cGVHD and aGVHD but wondered what the view from this forum may be.
Maybe I have missed it as I get bored to tears flipping through...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.28 |
Change
0.000(0.00%) |
Mkt cap ! $1.478B | |||
| Open | High | Low | Value | Volume |
| $1.29 | $1.31 | $1.27 | $969.2K | 753.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 12283 | $1.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.28 | 29239 | 11 |
View Market Depth
| Last trade - 13.03pm 05/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |